Published in Gene Therapy Weekly, September 21st, 1998
Pharmacologist Eric Wickstrom, PhD, and research associate Janet B. Smith, PhD, have used antisense therapy to prevent the development of Burkitt's lymphoma in laboratory mice, showing that this protection is aided by the mouse's own immunity.
One of the limitations of effectively treating Burkitt's lymphoma with chemotherapy is that the drugs eventually wear off, explained Wickstrom, professor of microbiology and immunology and a member of Jefferson's Kimmel Cancer Center and the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.